DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2056.00-8.9 (-0.43 %)
PREV CLOSE ( ) 2064.90
OPEN PRICE ( ) 2088.00
BID PRICE (QTY) 2055.75 (51)
OFFER PRICE (QTY) 2057.00 (54)
VOLUME 37676
TODAY'S LOW / HIGH ( )2041.95 2088.00
52 WK LOW / HIGH ( )1888 2788
NSE2053.00-12.65 (-0.61 %)
PREV CLOSE( ) 2065.65
OPEN PRICE ( ) 2077.80
BID PRICE (QTY) 2053.00 (113)
OFFER PRICE (QTY) 2053.50 (138)
VOLUME 458652
TODAY'S LOW / HIGH( ) 2041.00 2077.80
52 WK LOW / HIGH ( )1887 2787
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
12Jul Dr. Reddy's Lab soars on launching Hyd
Dr. Reddys Laboratories is currently trading at Rs. 2361.70, up by 59.00..
11Jul Dr. Reddy's Lab launches Hydroxychloro
Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets..
10Jul Tata Steel, Tata Motors and HCL Techno
Tata Steel has received the Odisha government's nod to sell iron ore fro..
09Jul Dr. Reddy’s Lab, UCB enter into agreem
Dr. Reddy’s Laboratories and UCB, a biopharmaceutical company, have ente..
04Jul Dr Reddys Laboratories submits copy of
In response to the Exchange Query, Dr Reddys Laboratories has submitted..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit17675669
Gross Profit 1955 6970
Operating Profit 399515339
Net Sales 2492393593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7269.95 (1.26%)
M.Cap (Rs. in Cr)15371.21
Astrazeneca Pharma I (BSE)
 1467.60 (3.08%)
M.Cap (Rs. in Cr)3661.38
Zim Laboratories (BSE)
 367.00 (4.86%)
M.Cap (Rs. in Cr)295.79
Hester Biosciences (BSE)
 1176.05 (1.12%)
M.Cap (Rs. in Cr)1000.45
Merck (BSE)
 2254.45 (0.44%)
M.Cap (Rs. in Cr)3679.25
Shareholding Pattern
NON-INSTITUTION 28.18%
PROMOTERS 26.76%
MUTUAL FUNDS/UTI 8.9%
FI/BANKS/INSURANCE 5.83%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.